News

COVID-19 Update

We hope this notice finds you, your friends and families as well as everyone at your company well. We wanted to take this time to briefly update you on how Valiance is responding to recent global events.

We are committed to continue servicing ALL our global clients serving the life sciences industry, many of which are directly responding to the COVID-19 crisis.

As these organizations work tirelessly to develop testing, vaccines and ultimately a cure for this pandemic, our team is busier than ever, having just completed a record quarter. In these unprecedented times, it’s not just compliance and quality on the line, but it’s also speed!

We are closely monitoring all updates on the COVID-19 situation and our team is following the recommendations offered by the Center for Disease Control and Prevention (CDC), along with all state and local agencies. As a result, our teams are taking the necessary safety precautions to protect our employees and our clients, working remotely to help minimize the spread of the illness.  We will continue to support you as you support the world.

Please feel free to contact us directly with additional questions.

Stay safe,
The Global Valiance Partners Family

Does Your Approach Compare to TRUcompare?

Migrations are a complex undertaking and traditional testing approaches often fall short of today’s business and compliance requirements. The ensuing risk can easily result in costly errors. The question is: How sound are your current testing and sampling approaches?